Meeting the Global NCD Target of at Least 10% Relative Reduction in the Harmful Use of Alcohol: Is the WHO European Region on Track?

Adult Alcohol Drinking Europe / epidemiology Female Global Health Humans Male Noncommunicable Diseases / epidemiology World Health Organization
NCD goals WHO European Region alcohol consumption alcohol control policy

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
14 05 2020
Historique:
received: 21 04 2020
revised: 08 05 2020
accepted: 09 05 2020
entrez: 20 5 2020
pubmed: 20 5 2020
medline: 28 10 2020
Statut: epublish

Résumé

The Global Action Plan for the Prevention and Control of Noncommunicable Diseases set the target of an "at least 10% relative reduction in the harmful use of alcohol, as appropriate, within the national context". This study investigated progress in the World Health Organization (WHO) European Region towards this target based on two indicators: (a) alcohol per capita consumption (APC) and (b) the age-standardized prevalence of heavy episodic drinking (HED). Alcohol exposure data for the years 2010-2017 were based on country-validated data and statistical models. Between 2010 and 2017, the reduction target for APC has been met with a decline by -12.4% (95% confidence interval (CI) -17.2, -7.0%) in the region. This progress differed greatly across the region with no decline for the EU-28 grouping (-2.4%; 95% CI -12.0, 7.8%) but large declines for the Eastern WHO EUR grouping (-26.2%; 95% CI -42.2, -8.1%). Little to no progress was made concerning HED, with an overall change of -1.7% (-13.7% to 10.2%) in the WHO European Region. The findings indicate a divergence in alcohol consumption reduction in Europe, with substantial progress in the Eastern part of the region and very modest or no progress in EU countries.

Sections du résumé

BACKGROUND
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases set the target of an "at least 10% relative reduction in the harmful use of alcohol, as appropriate, within the national context". This study investigated progress in the World Health Organization (WHO) European Region towards this target based on two indicators: (a) alcohol per capita consumption (APC) and (b) the age-standardized prevalence of heavy episodic drinking (HED).
METHODS
Alcohol exposure data for the years 2010-2017 were based on country-validated data and statistical models.
RESULTS
Between 2010 and 2017, the reduction target for APC has been met with a decline by -12.4% (95% confidence interval (CI) -17.2, -7.0%) in the region. This progress differed greatly across the region with no decline for the EU-28 grouping (-2.4%; 95% CI -12.0, 7.8%) but large declines for the Eastern WHO EUR grouping (-26.2%; 95% CI -42.2, -8.1%). Little to no progress was made concerning HED, with an overall change of -1.7% (-13.7% to 10.2%) in the WHO European Region.
CONCLUSIONS
The findings indicate a divergence in alcohol consumption reduction in Europe, with substantial progress in the Eastern part of the region and very modest or no progress in EU countries.

Identifiants

DOI: 10.3390/ijerph17103423 PMID: 32423032 PMC: PMC7277362
pubmed: 32423032
pii: ijerph17103423
doi: 10.3390/ijerph17103423
pmc: PMC7277362
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
Alcohol Alcohol. 2013 Mar-Apr;48(2):222-30
pubmed: 23299570
J Stud Alcohol Drugs. 2018 Jul;79(4):514-522
pubmed: 30079865
Soc Sci Med. 1997 Jan;44(2):251-60
pubmed: 9015877
Lancet. 2019 Jun 22;393(10190):2493-2502
pubmed: 31076174
Addiction. 2018 Jul;113(7):1231-1241
pubmed: 29377362
Drug Alcohol Rev. 2020 Jan 20;:
pubmed: 31960526
Br J Cancer. 2015 Feb 3;112(3):580-93
pubmed: 25422909
Eur J Public Health. 2019 Aug 1;29(4):723-728
pubmed: 31008515
Alcohol Alcohol. 2015 Sep;50(5):588-601
pubmed: 25964243
Addiction. 2019 Aug;114(8):1489-1494
pubmed: 31148313
Bull World Health Organ. 2010 Sep 1;88(9):643
pubmed: 20865064
Health Econ. 2001 Apr;10(3):257-70
pubmed: 11288191
Open Heart. 2014 Aug 06;1(1):e000135
pubmed: 25332827
J Glob Health. 2019 Jun;9(1):010421
pubmed: 31131099
Int J Drug Policy. 2020 May 14;80:102636
pubmed: 32417670
Trends Cardiovasc Med. 2017 Nov;27(8):534-538
pubmed: 28735784
Addiction. 2012 Jul;107(7):1246-60
pubmed: 22229788
Int J Drug Policy. 2011 Sep;22(5):326-34
pubmed: 21855312
Drug Alcohol Depend. 2017 Sep 1;178:126-129
pubmed: 28646715
Addiction. 2020 Apr;115(4):655-665
pubmed: 31475395
Alcohol Clin Exp Res. 2016 Jun;40(6):1166-81
pubmed: 27130687
Alcohol Alcohol. 2009 May-Jun;44(3):229-43
pubmed: 19144976
BMJ. 2019 Sep 25;366:l5274
pubmed: 31554617
Alcohol Alcohol. 2011 Mar-Apr;46(2):200-3
pubmed: 21273300

Auteurs

Charlotte Probst (C)

Heidelberg Institute of Global Health, Universitätsklinikum Heidelberg, 69120 Heidelberg, Germany.
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario M5S 2S1, Canada.

Jakob Manthey (J)

Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, 01187 Dresden, Germany.
Center for Interdisciplinary Addiction Research, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Maria Neufeld (M)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario M5S 2S1, Canada.
Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, 01187 Dresden, Germany.
Division of Noncommunicable Diseases and Promoting Health through the Life-course WHO European Office for Prevention and Control of Noncommunicable Diseases (NCD Office), 125009 Moscow, Russia.

Jürgen Rehm (J)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario M5S 2S1, Canada.
Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, 01187 Dresden, Germany.
World Health Organization/Pan American Health Organization Collaborating Centre, Centre for Addiction and Mental Health, Toronto, ON M5S 2S1, Canada.
Institute of Medical Science, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario M5G 2C1, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario M5T 3M7, Canada.
Department of International Health Projects, Institute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, , 119992 Moscow, Russia.

João Breda (J)

Division of Noncommunicable Diseases and Promoting Health through the Life-course WHO European Office for Prevention and Control of Noncommunicable Diseases (NCD Office), 125009 Moscow, Russia.

Ivo Rakovac (I)

Division of Noncommunicable Diseases and Promoting Health through the Life-course WHO European Office for Prevention and Control of Noncommunicable Diseases (NCD Office), 125009 Moscow, Russia.

And Carina Ferreira-Borges (AC)

Division of Noncommunicable Diseases and Promoting Health through the Life-course WHO European Office for Prevention and Control of Noncommunicable Diseases (NCD Office), 125009 Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Meeting the Global NCD Target of at Least 10%...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Comportement dipsique › Consommation d'alcool › Meeting the Global NCD Target of at Least 10%...
questionsmedicales.fr › Régions géographiques › Europe › Meeting the Global NCD Target of at Least 10%...
questionsmedicales.fr › Caractéristiques de la population › Santé › Santé mondiale › Meeting the Global NCD Target of at Least 10%...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Meeting the Global NCD Target of at Least 10%...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladies non transmissibles › Meeting the Global NCD Target of at Least 10%...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Agences internationales › Nations Unies › Organisation mondiale de la santé › Meeting the Global NCD Target of at Least 10%...